Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

154.65
-2.8900-1.83%
Post-market: 155.000.3500+0.23%19:44 EDT
Volume:1.22M
Turnover:189.49M
Market Cap:295.07B
PE:23.38
High:155.93
Open:155.93
Low:154.43
Close:157.54
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.02
T/O Rate:0.07%
Dividend:4.67
Dividend Rate:3.02%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.10
PE(LYR):21.63

Loading ...

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS
·
May 22

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

MT Newswires Live
·
May 18

Novartis Says Prostate Cancer Treatment Lowers Progression Risk By 58%

MT Newswires Live
·
May 18

Novartis announces new data from PSMAddition

TIPRANKS
·
May 18

Dyne Can Unlock Value in Two Drug Prospects, RBC Says

MT Newswires Live
·
May 13

Novartis breaks ground on radioligand therapy manufacturing site in Texas

TIPRANKS
·
May 08

Novartis Starts Construction on Texas Cancer Therapy Manufacturing Facility

MT Newswires Live
·
May 08

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Novartis Gains Canada Nod for Fabhalta in Rare Kidney Disease

MT Newswires Live
·
May 02

Novartis to Build Drug Ingredient Manufacturing Site in North Carolina

Dow Jones
·
Apr 30

Novartis AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 28

Novartis Shares Decline Following Disappointing Quarterly Results

Deep News
·
Apr 28

US Equity Futures Mostly Lower Pre-Bell Amid Continued Middle East Standoff, AI Spending Concerns

MT Newswires Live
·
Apr 28

Sector Update: Health Care

MT Newswires Live
·
Apr 28

Novartis reports Q1 core EPS $1.99 vs. $2.28 last year

TIPRANKS
·
Apr 28

Novartis Chief Predicts Trump's Drug Pricing Policy to Unfold Over Next Year and a Half

Deep News
·
Apr 28

European Pharma Stocks Slip After Novartis Books Sales, Profit Drop -- Market Talk

Dow Jones
·
Apr 28

Novartis Misses Quarterly Profit Estimates on Steep Generic Erosion

Reuters
·
Apr 28

Novartis Reaffirms FY2026 Outlook; Net Sales to Grow Low Single-Digit, Core Operating Income to Decline Low Single-Digit

Benzinga Earnings
·
Apr 28

Novartis Q1 Adj. EPS $1.99 Misses $2.13 Estimate, Sales $13.113B Miss $13.648B Estimate

Benzinga Earnings
·
Apr 28